Clinical Trial Update: Comparison of Esketamine Nasal Spray vs.Aripiprazole in Treat.Resistant Major Depressive Disorder in Elderly Patients [Phase 3]

View source ↗

Summary

Phase 3 clinical trial comparing esketamine nasal spray with aripiprazole for treatment-resistant major depressive disorder in elderly patients. The study statu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• ARIPIPRAZOLE (Aripiprazole)
• Esketamine nasal spray (esketamine)

Snippet

Sponsor: Fundación Pública Andaluza para la gestión de la Investigación en Sevilla | Conditions: Depressive Disorder | Phase 3 | Status: NOT_YET_RECRUITING